lestaurtinib has been researched along with Disease Models, Animal in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, Y; Kong, S; Meng, Y; Qi, Y; Shang, S; Xin, Y | 1 |
| Breen, M; Richards, KL; Seiser, EL; Small, GW; Suter, SE; Thomas, R | 1 |
| Hudkins, RL; Miknyoczki, SJ; Ruggeri, BA; Singh, J | 1 |
| Dalrymple, SL; Denmeade, SR; Dionne, CA; Isaacs, JT; Lamb, JC; Miknyoczki, S; Weeraratna, AT | 1 |
1 review(s) available for lestaurtinib and Disease Models, Animal
| Article | Year |
|---|---|
Role of neurotrophin-trk interactions in oncology: the anti-tumor efficacy of potent and selective trk tyrosine kinase inhibitors in pre-clinical tumor models.
Topics: Animals; Antineoplastic Agents; Carbazoles; Disease Models, Animal; Drug Design; Female; Furans; Humans; Indole Alkaloids; Indoles; Mice; Nerve Growth Factors; Nerve Tissue Proteins; Protein-Tyrosine Kinases; Signal Transduction | 1999 |
3 other study(ies) available for lestaurtinib and Disease Models, Animal
| Article | Year |
|---|---|
Lestaurtinib potentiates TRAIL-induced apoptosis in glioma via CHOP-dependent DR5 induction.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carbazoles; Caspases; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Dose-Response Relationship, Drug; Furans; Gene Expression Regulation, Neoplastic; Glioma; Humans; Mice; Mice, Knockout; Receptors, TNF-Related Apoptosis-Inducing Ligand; RNA, Small Interfering; TNF-Related Apoptosis-Inducing Ligand; Transcription Factor CHOP; Xenograft Model Antitumor Assays | 2020 |
FLT3 mutations in canine acute lymphocytic leukemia.
Topics: Amino Acid Sequence; Animals; Blotting, Western; Carbazoles; Cell Line, Tumor; Cell Proliferation; Cell Survival; Disease Models, Animal; DNA Mutational Analysis; DNA, Neoplasm; Dogs; Dose-Response Relationship, Drug; Extracellular Signal-Regulated MAP Kinases; fms-Like Tyrosine Kinase 3; Furans; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Molecular Sequence Data; Mutation; Phosphorylation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Reverse Transcriptase Polymerase Chain Reaction; STAT5 Transcription Factor | 2011 |
Pan-trk inhibition decreases metastasis and enhances host survival in experimental models as a result of its selective induction of apoptosis of prostate cancer cells.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Apoptosis; Carbazoles; Cell Division; Cell Line; Disease Models, Animal; Furans; Humans; Indoles; Male; Mice; Mice, Nude; Neoplasm Metastasis; Prostate-Specific Antigen; Prostatic Neoplasms; Rats; Receptor, trkA; Survival Analysis; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2001 |